Tag: Pfizer

US expects 100 million people vaccinated by February

WASHINGTON, United States (AFP) — The US hopes to have immunized 100 million people against Covid-19 by the end of February, a top official said Wednesday, which is approximately 40 percent of the country’s adult population. The push should start within weeks, when vaccines developed by Pfizer-BioNTech and Moderna-NIH are expected to be approved. Each of these require two doses, the second after three weeks and four weeks, respectively. “Between mid-December, and the end of […]

In historic first, UK to introduce Pfizer-BioNTech vaccine next week

by Jitendra JOSHI LONDON, United Kingdom (AFP) — Britain on Wednesday became the first Western country to approve a Covid-19 vaccine for general use, announcing a rollout of Pfizer-BioNTech’s drug from next week in a historic advance for humanity’s fightback against the coronavirus. “Help is on its way,” health secretary Matt Hancock tweeted as his department announced emergency use approval by the UK’s independent Medicines and Healthcare products Regulatory Agency (MHRA). “The NHS (National Health […]

US Operation Warp Speed backed vaccines for whole world

by Ivan Couronne Agence France Presse WASHINGTON, United States (AFP) — President Donald Trump’s announcement in May of plans to develop a Covid-19 vaccine by year’s end is near realization — despite a setback among one of the six candidates that the US supported. The president described the effort as “a massive scientific, industrial and logistical endeavor unlike anything our country has seen since the Manhattan Project,” alluding to the US program during World War […]

Best case scenario: COVID vaccines by May or July next year; 25M-30M to be vaccinated yearly

Galvez cites supply-demand challenge; need for ultra cold chain storage, distribution (Eagle News) — The Philippine COVID-19 czar said that vaccines for COVID-19 would only be made available by May, June or July next year in a best case scenario because of various challenges including vaccine supply and high demand in the world market. Secretary Carlito Galvez Jr., said that vaccines might not still be available this in the first or second quarter of 2021. “Dahil […]

In Brazil, Pfizer begins process to register Covid-19 vaccine

SAO PAULO, Brazil (AFP) — Pfizer gave the office of Brazil’s health regulators results of the tests of their Covid-19 vaccine, a necessary step to approve and register the vaccine, the US-based pharmaceutical said Wednesday. “This is an important step so that the vaccine can be available in Brazil,” Pfizer said in a statement in Portuguese. Brazil, with a population of 212 million, has the highest Covid-19 death rate in the world after the United […]

Pfizer/BioNTech seek first vaccine approval in US

  by Ivan Couronne with Yann Schreiber in Mainz Agence France Presse WASHINGTON, United States (AFP) — US biotech giant Pfizer and German partner BioNTech sought approval Friday to roll out their coronavirus vaccine early, a first step towards relief as surging infections prompt a return to shutdowns that traumatized nations and the global economy earlier this year. The world is looking to scientists for salvation from the global pandemic. The US Food and Drug […]

What are clinical trials and how do they work?

  by Ivan Couronne Agence France Presse WASHINGTON, United States (AFP) — To find out whether experimental Covid-19 vaccines are safe and effective, researchers design clinical trials involving thousands of volunteers, divided into groups that receive either the drug under investigation or a placebo. Data from such trials have shown that two vaccines — one developed by Pfizer and BioNtech, the other by Moderna and the US National Institutes of Health — are about 95 […]

Pfizer/BioNTech say results show Covid vaccine 95% effective

by Issam Ahmed WASHINGTON, United States (AFP) — Pfizer and BioNTech said Wednesday a completed analysis of their experimental Covid-19 vaccine found it protected 95 percent of people against the disease and announced they were applying for US emergency approval “within days.” The news from the US pharmaceutical company and its German partner brought further hope to a world upended by the coronavirus pandemic, and follows an announcement last week in which they said a […]

Pfizer ‘very close’ to applying for US emergency approval, says CEO

WASHINGTON, United States (AFP) — Pfizer is “very close” to applying for an emergency use approval for its Covid-19 vaccine after collecting safety data to submit to US regulators, the company’s CEO said Tuesday, according to a report. The pharmaceutical giant announced last week preliminary results from a late-stage clinical trial showing the injections it had co-developed with Germany’s BioNTech was more than 90 percent effective after the second dose. “We are very close to […]

Frontrunners emerge in race for Covid-19 vaccine

PARIS, France (AFP) — Dozens of companies, from biotech start-ups to Big Pharma, are racing to develop a safe and effective Covid-19 vaccine, both to meet urgent medical need and for the potential payday. Here’s an update on the quest for a magic bullet against the coronavirus that has already killed more than a million people worldwide. How many in the pipeline? The World Health Organization (WHO) has identified 42 “candidate vaccines” at the stage […]

Covid-19 vaccine ‘best science news’ of 2020

by Nina LARSON Agence France-Presse GENEVA, Switzerland (AFP) — Data indicating that a vaccine being developed against Covid-19 is highly effective is the “best science news of the year”, a pharmaceutical industry association chief said, voicing hope that other vaccine candidates would show equally good results. “A vaccine that has 90 percent efficacy and is pretty safe, that is a historic breakthrough,” the head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Thomas […]

Pfizer CEO sold $5.6 million in stock on day of vaccine announcement

WASHINGTON, United States (AGP) — Pfizer CEO Albert Bourla sold $5.6 million of his stock in the US pharmaceutical company on the same day it announced promising results for its Covid-19 vaccine candidate, filings showed Wednesday. The company, however, has reportedly said the sale was part of a pre-arranged periodic divestment plan when the stock reaches a certain price. According to a disclosure with US market regulator SEC, Bourla sold 132,508 shares at $41.94 each […]